A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Bone

• Publication date

  2001-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S8756-3282(01)00586-5PMID 11595624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications

  2010cited by this paper
• The Autosomal Dominant Hypophosphatemic Rickets (ADHR) Gene Is a Secreted Polypeptide Overexpressed by Tumors that Cause Phosphate Wasting

  2001cited by this paper
• The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

  2001cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Tumor-induced osteomalacia and the regulation of phosphate homeostasis.

  2000cited by this paper
• Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.

  2000cited by this paper
• Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group

  2000cited by this paper
• Coordinated Maturational Regulation of PHEX and Renal Phosphate Transport Inhibitory Activity: Evidence for the Pathophysiological Role of PHEX in X‐Linked Hypophosphatemia

  1999cited by this paper
• Cloning of Human PEX cDNA

  1998cited by this paper
• Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia.

  1997cited by this paper
• Expression and cloning of the human X-linked hypophosphatemia gene cDNA.

  1997cited by this paper
• Phosphatonin--a new phosphaturetic hormone? (lessons from tumour-induced osteomalacia and X-linked hypophosphataemia)

  1997cited by this paper
• Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13.

  1997cited by this paper
• Parathyroid Hormone-dependent Degradation of Type II Na+/Pi Cotransporters*

  1997cited by this paper
• Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets.

  1997cited by this paper
• Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia.

  1996cited by this paper
• Characteristics of tumor cell bioactivity in oncogenic osteomalacia.

  1996cited by this paper
• Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone.

  1996cited by this paper
• Principles of Bone Biology

  1996cited by this paper
• Hypophosphatemia Induced in Mice by Transplantation of a Tumor-Derived Cell Line from a Patient with Oncogenic Rickets

  1996cited by this paper
• Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse.

  1996cited by this paper
• Inhibitors of renal epithelial phosphate transport in tumor-induced osteomalacia and uremia.

  1995cited by this paper
• Bone scan in tumor-induced osteomalacia.

  1995cited by this paper
• Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.

  1995cited by this paper
• Oncogenic osteomalacia induced by schwannoma in a patient with neurofibromatosis.

  1994cited by this paper
• Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.

  1994cited by this paper
• A neuroendocrine cause of oncogenic osteomalacia

  1992cited by this paper
• Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients

  1992cited by this paper
• Circulating levels of midregional parathyroid hormone‐related protein in hypercalcaemia of malignancy

  1992cited by this paper
• Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.

  1989cited by this paper
• Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.

  1988cited by this paper
• Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets

  1987cited by this paper
• Multiple cytogenetic aberrations in neurofibrosarcomas complicating neurofibromatosis.

  1986cited by this paper
• The intermediate filament complement of the spectrum of nerve sheath neoplasms.

  1986cited by this paper
• Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases

  1986cited by this paper
• PARATHYROID HORMONE‐LIKE BIOACTIVITY IN TUMOURS FROM PATIENTS WITH ONCOGENIC OSTEOMALACIA

  1985cited by this paper
• Vitamin D resistant osteomalacia.

  1956cited by this paper
• Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years.

  1947cited by this paper

• Bisphosphonates in a kidney transplant recipient with persistent hyperparathyroidism: think twice

  2025cites this paper
• Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas.

  2024cites this paper
• Phosphaturic Mesenchymal Tumor Along the Hallux side Inducing a Chronic non-Healing Wound: A Case Report with Literature Review

  2022cites this paper
• Phosphatonins

  2021cites this paper
• A case of tumor-induced osteomalacia caused by giant cell reparative granuloma in the maxilla

  2019cites this paper
• Tumor induced osteomalacia in head and neck region: single center experience and systematic review

  2019cites this paper
• Giant Cell Tumor of Tendon Sheath Revealed on 68Ga-DOTA-TATE PET/CT in a Patient With Suspicious Tumor-Induced Osteomalacia.

  2019cites this paper
• Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review

  2018cites this paper
• Neurinome lombaire associé à une ostéoporose et un déficit en 25OH vitamine D3 : quel rapport ?

  2015cites this paper
• Physiology of the developing kidney: Disorders and therapy of calcium and phosphorous homeostasis

  2015cites this paper
• Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy.

  2013cites this paper
• Clinical Disturbances of Phosphate Homeostasis

  2013cites this paper
• Insights from genetic disorders of phosphate homeostasis.

  2013cites this paper
• Familial Hypophosphatemia and Related Disorders

  2012cites this paper
• Radiology of Rickets and Osteomalacia

  2011cites this paper
• Oncogenic osteomalacia due to phosphaturic mesenchymal tumor of the craniofacial sinuses.

  2011cites this paper
• AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.

  2011cites this paper
• Mycobacterium leprae downregulates the expression of PHEX in Schwann cells and osteoblasts.

  2010cites this paper
• Lambert–eaton myasthenic syndrome associated with gastric schwannoma

  2010cites this paper
• Metabolic Bone Disease

  2009cites this paper
• Founders lecture 2007

  2009cites this paper
• Endocrine Regulation of Phosphate Homeostasis

  2009cites this paper
• CHAPTER 70 – Clinical Disturbances of Phosphate Homeostasis

  2008cites this paper
• Genetic Disorders of Calcium and Phosphate Homeostasis

  2008cites this paper
• Chapter 16 – Phosphatonins

  2008cites this paper
• Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.

  2008cites this paper
• Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23.

  2008cites this paper
• Oncogenic osteomalacia: induced by tumor, cured by surgery.

  2007cites this paper
• Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia

  2006cites this paper
• Growth of Benign and Malignant Schwannoma Xenografts in Severe Combined Immunodeficiency Mice

  2006cites this paper
• Fibroblast growth factor-23 increases mouse PGE2 production in vivo and in vitro.

  2006cites this paper
• The phosphatonins and the regulation of phosphorus homeostasis

  2005cites this paper
• Elevated fibroblast growth factor‐23 in hypophosphatemic linear nevus sebaceous syndrome

  2005influential citation
• The Role of Drosophila Merlin in the Control of Mitosis Exit and Development

  2005cites this paper
• “Phosphatonins” and the regulation of phosphorus homeostasis

  2005cites this paper
• Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules.

  2005cites this paper
• Fibroblast growth factor-23 increases mouse PGE 2 production in vivo and in vitro

  2005cites this paper
• CHAPTER 60 – Radiology of Rickets and Osteomalacia

  2005cites this paper
• Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity: An Analysis of 32 Cases and a Comprehensive Review of the Literature

  2004cites this paper
• CHAPTER 25 – Familial Hypophosphatemia and Related Disorders

  2003cites this paper
• Human Fibroblast Growth Factor-23 Mutants Suppress Na+-dependent Phosphate Co-transport Activity and 1α,25-Dihydroxyvitamin D3 Production*

  2003cites this paper
• Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma.

  2003cites this paper
• Fibroblast growth factor 23 concentrations in humoral hypercalcemia of malignancy and hyperparathyroidism.

  2003cites this paper
• A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan.

  2003cites this paper
• A human schwannoma cell line supports the in vitro adhesion of Plasmodium falciparum infected erythrocytes to chondroitin-4-sulfate

  2003cites this paper
• Klinische Aspekte der onkogenen Osteomalzie

  2002cites this paper
• Phosphatonins: a new class of phosphate-regulating proteins

  2002cites this paper
• Oncogenic Osteomalacia

  2002cites this paper
• Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin

  2002cites this paper